[严重穆伦的病例报告]
Meriem Meddahi1, Alexandre Denoyer2, Fanny Pouillard3
1Service d'ophtalmologie, CHU de Reims, rue du Général-Koenig, 51100 Reims, France.
Annales de pathologie
|October 31, 2024
概括
穆伦,一种自身免疫性角膜疾病,呈现为外周. 诊断需要排除全身性疾病,并且经常需要组织病理学来确认.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 穆伦是一种外周角膜,与对角膜 stromal 抗原 (calgranulin C) 的自身免疫有关.
- 角质参与通常是孤立的,与伪穆伦 (与系统性疾病相关) 的区别至关重要.
- 诊断往往是排除的诊断,需要进行彻底的病因学工作.
研究的目的:
- 报告一个78岁的女性患有穆伦的病例.
- 突出诊断挑战和组织病理学的作用.
- 强调多学科方法在治疗穆伦的重要性.
主要方法:
- 一个78岁的红眼和光恐惧症的女性的临床表现.
- 检查显示有一个穿孔的周边膜与虹膜脱落.
- 诊断基于周围性角膜炎,负面的病因工作和解剖病理学分析.
主要成果:
- 这位患者出现了严重的视力障碍 (计数手指) 和穿孔的角膜.
- 角膜的组织病理学分析支持了穆伦的诊断.
- 排除全身性疾病是诊断的一个关键因素.
结论:
- 穆伦的诊断可能是具有挑战性的,需要全面的方法.
- 组织病理学检查可以为诊断提供有价值的数据.
- 多学科团队 (眼科医生,病理学家,内科医生) 对于最佳的患者结果至关重要.
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
232
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
232
Peptic Ulcer Disease I: Introduction
139
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
139
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
89
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
89
Peptic Ulcer Disease II: Pathophysiology
297
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
297


